Mersana Therapeutics's market cap is currently $39.63M. The company's EPS TTM is $-4.87; its P/E ratio is ―; Mersana Therapeutics is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-1.54. See an overview of income statement, balance sheet, and cash flow financials.
